Ectodomain shedding of the glycoprotein GP of Ebola virus.

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci U S A (2009) 4.38

Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J Virol (2005) 2.25

Antigenic subversion: a novel mechanism of host immune evasion by Ebola virus. PLoS Pathog (2012) 2.09

Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol (2006) 1.76

Ebolavirus glycoprotein structure and mechanism of entry. Future Virol (2009) 1.56

Protective efficacy of neutralizing monoclonal antibodies in a nonhuman primate model of Ebola hemorrhagic fever. PLoS One (2012) 1.54

Active-site determinants of substrate recognition by the metalloproteinases TACE and ADAM10. Biochem J (2009) 1.49

Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol (2005) 1.47

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. J Virol (2011) 1.44

The Myeloid LSECtin Is a DAP12-Coupled Receptor That Is Crucial for Inflammatory Response Induced by Ebola Virus Glycoprotein. PLoS Pathog (2016) 1.39

Forty-five years of Marburg virus research. Viruses (2012) 1.34

Steric shielding of surface epitopes and impaired immune recognition induced by the ebola virus glycoprotein. PLoS Pathog (2010) 1.29

Neutralizing ebolavirus: structural insights into the envelope glycoprotein and antibodies targeted against it. Curr Opin Struct Biol (2009) 1.28

Ebolavirus glycoprotein GP masks both its own epitopes and the presence of cellular surface proteins. J Virol (2009) 1.23

Crimean-congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein. J Virol (2006) 1.21

The temporal program of peripheral blood gene expression in the response of nonhuman primates to Ebola hemorrhagic fever. Genome Biol (2007) 1.20

The Ebola virus glycoprotein contributes to but is not sufficient for virulence in vivo. PLoS Pathog (2012) 1.16

Evolution and Spread of Ebola Virus in Liberia, 2014-2015. Cell Host Microbe (2015) 1.09

Molecular and cellular mechanisms of ectodomain shedding. Anat Rec (Hoboken) (2010) 1.08

Shed GP of Ebola virus triggers immune activation and increased vascular permeability. PLoS Pathog (2014) 1.06

Activation of triggering receptor expressed on myeloid cells-1 on human neutrophils by marburg and ebola viruses. J Virol (2006) 1.05

Anti-tetherin activities of HIV-1 Vpu and Ebola virus glycoprotein do not involve removal of tetherin from lipid rafts. J Virol (2012) 1.02

The secret life of viral entry glycoproteins: moonlighting in immune evasion. PLoS Pathog (2013) 1.00

Detection of cell-cell fusion mediated by Ebola virus glycoproteins. J Virol (2006) 0.98

Two synthetic antibodies that recognize and neutralize distinct proteolytic forms of the ebola virus envelope glycoprotein. Chembiochem (2012) 0.97

Uncoupling GP1 and GP2 expression in the Lassa virus glycoprotein complex: implications for GP1 ectodomain shedding. Virol J (2008) 0.93

Molecular architecture of the human sperm IZUMO1 and egg JUNO fertilization complex. Nature (2016) 0.91

Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J Virol (2011) 0.89

Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection. J Infect Dis (2011) 0.89

Less is more: Ebola virus surface glycoprotein expression levels regulate virus production and infectivity. J Virol (2014) 0.88

Shedding of soluble glycoprotein 1 detected during acute Lassa virus infection in human subjects. Virol J (2010) 0.83

Peptidase specificity from the substrate cleavage collection in the MEROPS database and a tool to measure cleavage site conservation. Biochimie (2015) 0.82

Characterization of the Lassa virus GP1 ectodomain shedding: implications for improved diagnostic platforms. Virol J (2009) 0.81

The Role of Conserved N-Linked Glycans on Ebola Virus Glycoprotein 2. J Infect Dis (2015) 0.80

A Kunjin Replicon Virus-like Particle Vaccine Provides Protection Against Ebola Virus Infection in Nonhuman Primates. J Infect Dis (2015) 0.79

Predictive and comparative analysis of Ebolavirus proteins. Cell Cycle (2015) 0.79

Modulation of CD163 expression by metalloprotease ADAM17 regulates porcine reproductive and respiratory syndrome virus entry. J Virol (2014) 0.78

A strategy for O-glycoproteomics of enveloped viruses--the O-glycoproteome of herpes simplex virus type 1. PLoS Pathog (2015) 0.77

Anti-EBOV GP IgGs Lacking α1-3-Galactose and Neu5Gc Prolong Survival and Decrease Blood Viral Load in EBOV-Infected Guinea Pigs. PLoS One (2016) 0.76

Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis. PLoS Pathog (2015) 0.76

Protein engineering strategies for the development of viral vaccines and immunotherapeutics. FEBS Lett (2013) 0.76

Successful post-exposure prophylaxis of Ebola infected non-human primates using Ebola glycoprotein-specific equine IgG. Sci Rep (2017) 0.75

Fighting Ebola: A Window for Vaccine Re-evaluation? PLoS Pathog (2017) 0.75

Mechanistic understanding of N-glycosylation in Ebola virus glycoprotein maturation and function. J Biol Chem (2017) 0.75

Cooperation of the Ebola proteins VP40 and GP1,2 with BST2 to activate NF-κβ independently of virus-like particle trapping. J Virol (2017) 0.75

A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells. Nature (1997) 10.14

An essential role for ectodomain shedding in mammalian development. Science (1998) 9.14

Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis. Lancet (1994) 7.04

The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing. Proc Natl Acad Sci U S A (1996) 7.02

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates. Nature (2003) 6.35

A novel proteolytic cleavage involved in Notch signaling: the role of the disintegrin-metalloprotease TACE. Mol Cell (2000) 5.53

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases. Virology (1995) 5.34

C-type lectins DC-SIGN and L-SIGN mediate cellular entry by Ebola virus in cis and in trans. J Virol (2002) 4.47

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology (1995) 4.39

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury. Nat Med (2000) 4.36

Processing of the Ebola virus glycoprotein by the proprotein convertase furin. Proc Natl Acad Sci U S A (1998) 4.33

Distinct cellular interactions of secreted and transmembrane Ebola virus glycoproteins. Science (1998) 4.24

Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J Exp Med (2002) 3.88

Evidence that tumor necrosis factor alpha converting enzyme is involved in regulated alpha-secretase cleavage of the Alzheimer amyloid protein precursor. J Biol Chem (1998) 3.83

Ebola virus can be effectively neutralized by antibody produced in natural human infection. J Virol (1999) 3.44

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity. Science (2001) 3.08

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus. J Virol (1998) 2.99

Functional analysis of the domain structure of tumor necrosis factor-alpha converting enzyme. J Biol Chem (2000) 2.92

Covalent modifications of the ebola virus glycoprotein. J Virol (2002) 2.84

Soluble receptors for cytokines and growth factors: generation and biological function. Biochem J (1994) 2.83

Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J Cell Sci (1999) 2.82

Membrane protein secretases. Biochem J (1997) 2.70

Passive immunization of Ebola virus-infected cynomolgus monkeys with immunoglobulin from hyperimmune horses. Arch Virol Suppl (1996) 2.69

Mutational analysis of the putative fusion domain of Ebola virus glycoprotein. J Virol (1999) 2.41

Folate receptor-alpha is a cofactor for cellular entry by Marburg and Ebola viruses. Cell (2001) 2.39

Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody. J Virol (2002) 2.31

Molecular characterization of guinea pig-adapted variants of Ebola virus. Virology (2000) 2.21

Ebola virus glycoprotein: proteolytic processing, acylation, cell tropism, and detection of neutralizing antibodies. J Virol (2001) 2.13

Proinflammatory response during Ebola virus infection of primate models: possible involvement of the tumor necrosis factor receptor superfamily. Immunol Lett (2002) 2.06

Release of viral glycoproteins during Ebola virus infection. Virology (1998) 1.73

Remarkable roles of proteolysis on and beyond the cell surface. Curr Opin Cell Biol (2000) 1.67

The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer. Virology (1998) 1.62

Differential induction of cellular detachment by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J Gen Virol (2000) 1.62

Ebola virus infection in guinea pigs: presumable role of granulomatous inflammation in pathogenesis. Arch Virol (1996) 1.53

The membrane-associated and secreted forms of the respiratory syncytial virus attachment glycoprotein G are synthesized from alternative initiation codons. J Virol (1994) 1.52

Shedding of interleukin-6 receptor and tumor necrosis factor alpha. Contribution of the stalk sequence to the cleavage pattern of transmembrane proteins. Eur J Biochem (2000) 1.32

The importance of shedding of membrane proteins for cytokine biology. Eur Cytokine Netw (2000) 1.21

Proteolytic release of membrane-bound angiotensin-converting enzyme: role of the juxtamembrane stalk sequence. Biochemistry (1996) 1.15

Functional and biochemical characterization of ADAMs and their predicted role in protein ectodomain shedding. Inflamm Res (2002) 1.13

Recognition sequences and structural elements contribute to shedding susceptibility of membrane proteins. Biochem J (2001) 1.02

Intracellular formation of two soluble glycoproteins in BHK cells infected with vesicular stomatitis virus serotype New Jersey. Virology (1991) 0.96

Emerging infections--Ebola and other filoviruses. West J Med (1996) 0.93

Shedding of Gs protein (a soluble form of the viral glycoprotein) by the rabies virus-infected BHK-21 cells. Virology (1993) 0.89

Characterization of a secreted form of measles virus haemagglutinin expressed from a vaccinia virus recombinant. J Gen Virol (1994) 0.84

Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med (2003) 27.97

Human and avian influenza viruses target different cell types in cultures of human airway epithelium. Proc Natl Acad Sci U S A (2004) 7.18

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses. Nat Med (2005) 6.77

Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med (2015) 5.92

Clinical care of two patients with Ebola virus disease in the United States. N Engl J Med (2014) 5.74

Overexpression of the alpha-2,6-sialyltransferase in MDCK cells increases influenza virus sensitivity to neuraminidase inhibitors. J Virol (2003) 5.11

Functional balance between haemagglutinin and neuraminidase in influenza virus infections. Rev Med Virol (2002) 5.09

An efficient method to make human monoclonal antibodies from memory B cells: potent neutralization of SARS coronavirus. Nat Med (2004) 4.89

The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J Virol (2003) 4.73

Marburgvirus genomics and association with a large hemorrhagic fever outbreak in Angola. J Virol (2006) 4.01

New low-viscosity overlay medium for viral plaque assays. Virol J (2006) 3.92

Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch Virol (2010) 3.77

Effective post-exposure treatment of Ebola infection. PLoS Pathog (2007) 3.69

Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J Virol (2006) 3.50

Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium. J Virol (2004) 3.43

Interaction of polymerase subunit PB2 and NP with importin alpha1 is a determinant of host range of influenza A virus. PLoS Pathog (2008) 3.37

Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment. Lancet (2006) 3.15

Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses. J Virol (2004) 2.99

Lassa virus Z protein is a matrix protein and sufficient for the release of virus-like particles [corrected]. J Virol (2003) 2.87

Proteolytic activation of influenza viruses by serine proteases TMPRSS2 and HAT from human airway epithelium. J Virol (2006) 2.80

Ebola virus: from discovery to vaccine. Nat Rev Immunol (2003) 2.72

Molecular Evidence of Sexual Transmission of Ebola Virus. N Engl J Med (2015) 2.71

Development of a new vaccine for the prevention of Lassa fever. PLoS Med (2005) 2.71

Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J Virol (2003) 2.57

Metabolic priming by a secreted fungal effector. Nature (2011) 2.56

General protein diffusion barriers create compartments within bacterial cells. Cell (2012) 2.48

Altered receptor specificity and cell tropism of D222G hemagglutinin mutants isolated from fatal cases of pandemic A(H1N1) 2009 influenza virus. J Virol (2010) 2.38

Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. Immunity (2012) 2.35

Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses. Vaccine (2008) 2.33

Crystal structure of the borna disease virus nucleoprotein. Structure (2003) 2.30

SARS--beginning to understand a new virus. Nat Rev Microbiol (2003) 2.30

Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J Infect Dis (2007) 2.22

Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J Virol (2006) 2.14

A conspicuous nickel protein in microbial mats that oxidize methane anaerobically. Nature (2003) 2.10

Cryo-electron tomography of Marburg virus particles and their morphogenesis within infected cells. PLoS Biol (2011) 2.02

DC-SIGN and DC-SIGNR interact with the glycoprotein of Marburg virus and the S protein of severe acute respiratory syndrome coronavirus. J Virol (2004) 1.92

Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor. EMBO Rep (2003) 1.85

Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine. J Virol (2006) 1.85

Mucosal immunization of cynomolgus macaques with the VSVDeltaG/ZEBOVGP vaccine stimulates strong ebola GP-specific immune responses. PLoS One (2009) 1.83

Denitrifying bacteria anaerobically oxidize methane in the absence of Archaea. Environ Microbiol (2008) 1.80

Inhibition of filovirus replication by the zinc finger antiviral protein. J Virol (2006) 1.76

The matrix protein VP40 from Ebola virus octamerizes into pore-like structures with specific RNA binding properties. Structure (2003) 1.75

Characterization of Zaire ebolavirus glycoprotein-specific monoclonal antibodies. Clin Immunol (2011) 1.73

Ebola virus VP30-mediated transcription is regulated by RNA secondary structure formation. J Virol (2002) 1.71

PomZ, a ParA-like protein, regulates Z-ring formation and cell division in Myxococcus xanthus. Mol Microbiol (2012) 1.70

Differential use of importin-α isoforms governs cell tropism and host adaptation of influenza virus. Nat Commun (2011) 1.65

VP40, the matrix protein of Marburg virus, is associated with membranes of the late endosomal compartment. J Virol (2002) 1.63

Two small GTPases act in concert with the bactofilin cytoskeleton to regulate dynamic bacterial cell polarity. Dev Cell (2013) 1.63

Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett (2003) 1.62

Management of accidental exposure to Ebola virus in the biosafety level 4 laboratory, Hamburg, Germany. J Infect Dis (2011) 1.62

Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function. J Virol (2005) 1.61

Infection of naive target cells with virus-like particles: implications for the function of ebola virus VP24. J Virol (2006) 1.61

Control of apoptosis in influenza virus-infected cells by up-regulation of Akt and p53 signaling. Apoptosis (2007) 1.61

Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Arch Virol (2012) 1.59

Phylogeny of the SARS coronavirus. Science (2003) 1.56

Characterization of the Lassa virus matrix protein Z: electron microscopic study of virus-like particles and interaction with the nucleoprotein (NP). Virus Res (2004) 1.54

The use of a mobile laboratory unit in support of patient management and epidemiological surveillance during the 2005 Marburg Outbreak in Angola. PLoS Negl Trop Dis (2011) 1.53

Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis. J Biol Chem (2005) 1.53

Human cell tropism and innate immune system interactions of human respiratory coronavirus EMC compared to those of severe acute respiratory syndrome coronavirus. J Virol (2013) 1.52

Natural and synthetic sialic acid-containing inhibitors of influenza virus receptor binding. Rev Med Virol (2003) 1.51

Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model. J Virol (2010) 1.49

Synthetic generation of influenza vaccine viruses for rapid response to pandemics. Sci Transl Med (2013) 1.47

Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann Intern Med (2015) 1.47

Role of Ebola virus secreted glycoproteins and virus-like particles in activation of human macrophages. J Virol (2005) 1.47

Reemerging Sudan Ebola virus disease in Uganda, 2011. Emerg Infect Dis (2012) 1.47

Multivesicular bodies as a platform for formation of the Marburg virus envelope. J Virol (2004) 1.47

Phosphorylation of VP30 impairs ebola virus transcription. J Biol Chem (2002) 1.47

VP24 of Marburg virus influences formation of infectious particles. J Virol (2005) 1.46

Avian-virus-like receptor specificity of the hemagglutinin impedes influenza virus replication in cultures of human airway epithelium. Virology (2007) 1.44

The matrix protein of Marburg virus is transported to the plasma membrane along cellular membranes: exploiting the retrograde late endosomal pathway. J Virol (2004) 1.43

Oligomerization and polymerization of the filovirus matrix protein VP40. Virology (2003) 1.42

The nipah virus fusion protein is cleaved within the endosomal compartment. J Biol Chem (2005) 1.42

Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J Virol (2010) 1.40

Influenza B virus with modified hemagglutinin cleavage site as a novel attenuated live vaccine. J Infect Dis (2011) 1.40

Structural dissection of Ebola virus and its assembly determinants using cryo-electron tomography. Proc Natl Acad Sci U S A (2012) 1.38

Morphology of Marburg virus NP-RNA. Virology (2002) 1.38

Crystal structure of the C-terminal domain of Ebola virus VP30 reveals a role in transcription and nucleocapsid association. Proc Natl Acad Sci U S A (2007) 1.37

Assessment of a vesicular stomatitis virus-based vaccine by use of the mouse model of Ebola virus hemorrhagic fever. J Infect Dis (2007) 1.37

LSECtin interacts with filovirus glycoproteins and the spike protein of SARS coronavirus. Virology (2005) 1.37

Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res (2008) 1.36

Middle East respiratory syndrome coronavirus spike protein delivered by modified vaccinia virus Ankara efficiently induces virus-neutralizing antibodies. J Virol (2013) 1.34

Analysis of the interaction of Ebola virus glycoprotein with DC-SIGN (dendritic cell-specific intercellular adhesion molecule 3-grabbing nonintegrin) and its homologue DC-SIGNR. J Infect Dis (2007) 1.33